Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has multiple attached files:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
733118
Reference Type
Journal Article
Title
Clinical spectroscopy: Seventy cases of generalized argyrosis following organic and colloidal silver medication, including a biospectrometric analysis of ten cases
Author(s)
Gaul, LE; Staud, AH
Year
1935
Is Peer Reviewed?
Yes
Journal
JAMA: Journal of the American Medical Association
ISSN:
0098-7484
EISSN:
1538-3598
Volume
104
Issue
16
Page Numbers
1387-1390
Language
English
DOI
10.1001/jama.1935.02760160011004
Abstract
The alarming increase of argyrosis leaves little doubt as to our purpose in this report. There has been an accumulation of indubitable clinical evidence which makes it imperative to present before those who prescribe, dispense or use these drugs the danger entailed therein. It must be emphasized that within the past year, following intranasal applications with Argyrol and Neo-Silvol in fifteen children under 10 years of age, an argyrosis developed. Ten of these fifteen children were girls. All these children will present throughout their lives a conspicuous and permanent bluish or slate-gray discoloration that will select them as objects of whispered comments by friends and strangers. At present there is no treatment for argyria.
Tags
Other
•
Nanoscale Silver
Final Case Study
Introduction to Document, Silver and Nanoscale Silver
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity